Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is associated with organ toxicities, including cardiovascular (CV) complications. Data on contemporary acute postallogeneic HSCT cardiac complications and their impact on survival are scant. Objectives: The aim of the study was to...

Full description

Bibliographic Details
Published in:JACC: Advances
Main Authors: Nazanin Aghel, MD, MSc, Vincent Wang, BHSc, Darryl Leong, MD, PhD, Michelle Lui, PharmD, MSc, Livia Fu, BNSc, MN, RN(EC), Jasmine Kang, MD, Dina Khalaf, MD, Irwin Walker, MD, Christopher Hillis, MD, MSc, Brian Leber, MD, Harry Klimis, MD, PhD, Anne Holbrook, MD, PharmD, MSc, Catherine Demers, MD, MSc, Philip Joseph, MD, MSc, Kylie Lepic, MD, Alejandro Garcia-Horton, MD, Tobias Berg, MD, PhD, Jeffrey Howard Lipton, MD, PhD, Mylinh Duong, MD, MSc, Jane Turner, MD, Jinhui Ma, PhD
Format: Article
Language:English
Published: Elsevier 2025-06-01
Subjects:
allogeneic stem cell transplantation
atrial fibrillation
cardiovascular events
heart failure
left ventricular dysfunction
nonrelapse mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25001772

Internet

http://www.sciencedirect.com/science/article/pii/S2772963X25001772

Similar Items